Durability of complete response (CR) with atezolizumab (atezo) in locally advanced/metastatic urothelial carcinoma (mUC) Meeting Abstract


Authors: Loriot, Y.; Balar, A. V.; Dreicer, R.; Hoffman-Censits, J. H.; Perez-Gracia, J. L.; Petrylak, D. P.; Van der Heijden, M. S.; Shen, X.; Zhu, Q.; Ding, B.; Kaiser, C.; Rosenberg, J. E.
Abstract Title: Durability of complete response (CR) with atezolizumab (atezo) in locally advanced/metastatic urothelial carcinoma (mUC)
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 270s
Language: English
ACCESSION: WOS:000487345805352
DOI: 10.1200/JCO.2019.37.15_suppl.4527
PROVIDER: wos
Notes: Meeting Abstract: 4527 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg